NEW: SARS-CoV-2 PepMixes™ for Brazil, South Africa & California Mutations

Published on 19/03/2021

As additional SARS-CoV-2 virus variants emerge, we remain committed to respond with PepMix™ peptide pools for cellular immune response profiling.

Here, we announce the launch of overlapping PepMix™ peptide pools representing the Spike protein and the corresponding RBD domain of the following SARS-CoV-2 variants of concern:


Please also find our latest Application Note providing access and descriptions of our entire Corona Virus Product Portfolio, as well as associated references!

We continue to appreciate your trust and support for the development of meaningful products to help fighting the COVID-19 pandemic.